Vasodilation induced by vasopressin V2 receptor stimulation in afferent arterioles

Kidney International

Volumn 49, Issue 3, 1996, Pages 722-729

  Tamaki, Toshiaki ^a   Kiyomoto, Kayo ^a   He, Hong ^a   Tomohiro, Atsufumi ^a   Nishiyama, Akira ^a   Aki, Yasuharu ^a   Kimura, Shoji ^a   Abe, Youichi ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 [1 [4 (3 ACETAMIDOPROPOXY)BENZOYL] 4 PIPERIDYL] 1,2,3,4 TETRAHYDRO 2 QUINOLINONE; ARGIPRESSIN; DESMOPRESSIN; MOZAVAPTAN; NORADRENALIN; VASOPRESSIN ANTAGONIST; VASOPRESSIN V2 RECEPTOR;

ANIMAL EXPERIMENT; ARTERIOLE; ARTICLE; GLOMERULUS; KIDNEY BLOOD FLOW; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; VASOCONSTRICTION; VASODILATATION;

EID: 0029878832     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.101     Document Type: Article

References (34)

1. OLIVER JA, SCIACCA RR, LE CREN G, CANNON PJ: Modulation by prostaglandins of the renal vascular action of arginine vasopressin. Prostaglandin 24:641-656, 1982
2. NAITOH M, SUZUKI H, MURAKAMI M, MATSUMOTO A, ICHIHARA A, NAKAMOTO H, YAMAMURA Y, SARUTA T: Arginine vasopressin produces renal vasodilation via V2 receptors in conscious dogs. Am J Physiol 265:R934-R942, 1993
3. LIARD JF: Cardiovascular effects associated with antidiuretic activity of vasopressin after blockade of its vasoactive action in dehydrated dogs. Circ Res 58:631-640, 1986
4. AL-OMAR AZZAWI S, SHIRLEY D: The effect of vasopressin on renal blood flow and its distribution in the rat. J Physiol 341:233-244, 1983
5. GELLAI M, SILVERSTEIN JH, HWANG J, LA ROCHELLA FT, VALTIN H: Influence of vasopressin on renal hemodynamics in conscious Brattleboro rats. Am J Physiol 246:F819-F827, 1984
6. HOFBAUER KG, CRISCIONE L, NEISIUS D, SONNENBURG C, WOOD JM: The role of peptide hormones in the control of renal blood flow, in Neuronal Messengers in Vascular Function. Amsterdam, Elsevier Science Publishers, 1987, pp 271-291
7. CARMINES PK, FLEMING JT: Control of the renal microvasculature by vasoactive peptide. FASEB J 4:3300-3309, 1990
8. BECK T, HASSID A, DUNN M: The effect of arginine vasopressin and its analogs on the synthesis of prostaglandin E2 by rat medullary interstitial cells in culture. J Pharmacol Exp Ther 215:15-19, 1980
9. WUTHRICH R, VALLOTTON M: Prostaglandin E2, cyclic AMP response to vasopressin in renal medullary tubular cells. Am J Physiol 251: F499-F505, 1986
10. AKI Y, TAMAKI T, KIYOMOTO H, HE H, YOSHIDA H, IWAO H, ABE Y: Nitric oxide may participate in V2 vasopressin-receptor-mediated renal vasodilation. J Cardiovasc Pharmacol 23:331-336, 1994
11. RUDICHENKO V, BEIERWALTES W: Arginine vasopressin-induced renal vasodilation mediated by nitric oxide. J Vasc Res 32:100-105, 1995
12. EDWARDS RM, TRIZNA W, KINTER L: Renal microvascular effects of vasopressin and vasopressin antagonists. Am J Physiol 256:F274-F278, 1989
13. WEIHPRECHT H, LORENZ JN, BRIGGS JP, SCHNERMANN J: Vasoconstrictor effect of angiotensin and vasopressin in isolated rabbit afferent arterioles. Am J Physiol 261:F273-F282, 1991
14. HARRISON BL, CARMINES PK: Juxtamedullary microvascular responses to arginine vasopressin in rat kidney. Am J Physiol 267:F249-F256, 1994
15. G-nitro-L-arginine on isolated afferent arterioles. Jap J Pharmacol 62:231-237, 1993
16. YOSHIDA H, TAMAKI T, AKI Y, KIMURA S, TAKENAKA I, ABE Y: Effects of angiotensin II on isolated rabbit afferent arterioles. Jap J Pharmacol 66:457-464, 1994
17. OSGOOD RW, PATTON M, HANLEY MJ, VENKATACHALAM M, REINECK HJ, STEIN JH: In vitro perfusion of the isolated dog glomerulus. Am J Physiol 244:F349-F354, 1983
18. ITO S, CARRERERO OA: An in vitro approch to the study of macula densa-mediated glomerular hemodynamics. Kidney Int 38:1206-1210, 1990
19. ITO S, JOHNSON C, CARRETERO O: Modulation of angiotensin II-induced vasoconstriction by endothelium-derived relaxing factor in the isolated microperfused rabbit afferent arteriole. J Clin Invest 87:1656-1663, 1991
20. YAMAMURA Y, OGAWA H, CHIHARA T, KONDO K, ONOGAWA T, NAKAMURA S, MORI T, TOMINAGA M, YABUUCHI Y: OPC-21268, an orally effective, nonpeptide vasopressin V1 receptor antagonist. Science 252:572-574, 1991
21. YAMAMURA Y, OGAWA H, YAMASHITA H, CHIHARA T, MIYAMOTO H, NAKAMURA S, ONOGAWA T, YAMASHITA T, HOSOKAWA T, MORI T, TOMINAGA M, YABUUCHI Y: Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist. Br J Pharmacol 105:787-791, 1992
22. SCHWARTZ J, LIARD JF, OTT C, COWLEY AW JR: Hemodynamic effects of neurohypophyseal peptides with antidiuretic activity in dogs. Am J Physiol 249:H1001-H1008, 1985
23. LIARD J: cAMP, extrarenal vasopressin V2 receptors in dogs. Am J Physiol 263:H1888-H1891, 1992
24. SUZUKI S, TAKESHITA A, IMAIZUMI T, HIROOKA Y, YOSHIDA M, ANDO S, NAKAMURA M: Biphasic forearm vascular responses to intraarterial arginine vasopressin. J Clin Invest 84:427-434, 1989
25. HIRSCH A, DZAU V, MAJZOUB J, CREAGER M: Vasopressin-mediated forearm vasodilation in normal humans. Evidence for a vascular vasopressin V2 receptor. J Clin Invest 84:418-426, 1989
26. BROMMER EJP, VAN BRUMMELEN P, DERKX FHM: Desmopressin, hypotension. Ann Intern Med 103:962, 1985
27. SCHMID PG, ABBOUD FM, WENDLING MG, RAMBERG ES, MARK AL, HEISTAD DD, ECKSTEIN JW: Regional vascular effects of vasopressin: Plasma level and circulatory responses. Am J Physiol 227:998-1004, 1974
28. UNDESSER K, HASSER E, HAYWOOD J, JOHNSON A, BISHOP V: Interaction of vasopressin with the area postrema in arterial baroreflex function in conscious rabbits. Cir Res 56:410-417, 1985
29. UNGER T, ROHMEISS P, DEMMERT G, GANTEN D, LANG R, LUFT F: Differential modulation of the baroreceptor reflex by brain and plasma vasopressin. Hypertension 8(Suppl II):II-157-II-162, 1986
30. ZIPSER RD, MYERS SI, NEEDLEMAN P: Stimulation of renal prostaglandin synthesis by the pressor activity of vasoptressin. Endocrinology 108:495-499, 1981
31. DUNN MJ, GREELY HP, VALTIN H, KINTER LB, BEEUWKES RI: Renal excretion of prestaglandins E2 and F2α in diabetes insipidus rats. Am J Physiol 235:E624-E627, 1978
32. SCHARSCHMIDT L, DUNN M: Prostaglandin synthesis by rat glomerular mesangial cells in culture. J Clin Invest 71:1756-1764, 1983
33. TAGAWA T, IMAIZUMI T, ENDO T, SHIRAMOTO M, HIROOKA Y, ANDO S, TAKESHITA A: Vasodilatory effect of arginine vasopressin is mediated by nitric oxide in human forearm vessels. J Clin Invest 92:1483-1490, 1993
34. LIARD JF: L-NAME antagonizes vasopressin V2-induced vasodilation in dogs. Am J Physiol 266:H99-H106, 1994